English
This article is from Surgical Neurology International , volume 4 . Abstract Background:: The health-related quality of life (HRQOL) measures serve as valuable indicators of survival in patients with newly diagnosed primary brain tumors (PBTs). HRQOL outcomes may benefit clinical decision-making by individualizing patient treatment and improving communications between the doctor, patient, and families. Exploring the individual items of the European Organization and Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QOL) measures may be predictive of prognosis. Methods:: We prospectively collected the validated HRQOL and standard clinical and radiological measures from 48 patients with newly diagnosed PBT. The patients were followed every 3 months over 2 years. No proxies were allowed. Questionnaire responses were compared between two groups: Patients with recurrence and/or death (n = 26) and patients without a recurrence (n = 22). A total of 17 patients succumbed to a tumor-related death. Statistical analysis utilizing nonparametric t-tests and Wilcoxon sign tests assessed QOL responses. Results:: Significant group differences were noted in the QOL measures with m
Sign in with your free account to read, download EPUBs or listen.
Ebook · Quality of life measures as a preliminary clinical indicator in patients with primary brain tumors. · Shields, Lisa B. E, Choucair, Aliisha, Choucair, Ali K. · Internet Archive